搜尋結果
文章
Yan, K. H. ,
Yao, C. J. ,
Hsiao, C. H. ,
Lin, K. H. ,
Lin, Y. W. ,
Wen, Y-C. ,
Liu, C. C. ,
Yan, M. D. ,
Chuang, S. E. ,
Lai, G. M. &
Lee, L. M. ,
10月 2013 ,
於: Oncology Letters. 5 ,
5 ,
p. 1541-1545 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mefloquine
100%
Adenosine Monophosphate
79%
Extracellular Signal-Regulated MAP Kinases
76%
Protein Kinases
65%
Reactive Oxygen Species
56%
Yan, K. H. ,
Lin, Y. W. ,
Hsiao, C. H. ,
Wen, Y-C. ,
Lin, K. H. ,
Liu, C. C. ,
Hsieh, M-C. ,
Yao, C. J. ,
Yan, M. D. ,
Lai, G. M. ,
Chuang, S. E. &
Lee, L. M. ,
10月 2013 ,
於: Oncology Letters. 5 ,
5 ,
p. 1567-1571 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mefloquine
100%
Prostatic Neoplasms
56%
Cell Death
53%
PC-3 Cells
38%
diacetyldichlorofluorescein
22%
Cho, C. Y. ,
Huang, J. S. ,
Shiah, S. G. ,
Chung, S. Y. ,
Lay, J. D. ,
Yang, Y. Y. ,
Lai, G. M. ,
Cheng, A. L. ,
Chen, L. T. &
Chuang, S. E. ,
2月 2016 ,
於: RNA. 22 ,
2 ,
p. 303-315 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
MicroRNAs
100%
Lung Neoplasms
93%
Activating Transcription Factors
87%
Apoptosis
72%
MAP Kinase Signaling System
65%
Hsiao, P. C. ,
Lee, W-J. ,
Yang, S. F. ,
Tan, P. ,
Chen, H. Y. ,
Lee, L-M. ,
Chang, J. L. ,
Lai, G-M. ,
Chow, J-M. &
Chien, M-H. ,
12月 1 2014 ,
於: Tumor Biology. 35 ,
12 ,
p. 11903-11911 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
nobiletin
100%
Caspase 8
69%
Myeloid Cells
61%
Acute Myeloid Leukemia
57%
Apoptosis
36%
Kao, R. H. ,
Lai, G. M. ,
Chow, J. M. ,
Liao, C. H. ,
Zheng, Y. M. ,
Tsai, W. L. ,
Hsia, S. ,
Lai, I. C. ,
Lee, H. L. ,
Chuang, S. E. ,
Whang-Peng, J. &
Yao, C. J. ,
10月 8 2018 ,
於: Nutrients. 10 ,
10 , 1458.
研究成果: 雜誌貢獻 › 文章 › 同行評審
AMP-activated protein kinase
100%
Fish Oils
89%
AMP-Activated Protein Kinases
86%
adenocarcinoma
86%
Selenium
80%
Chen, J-H. ,
Yen, Y-C. ,
Liu, S. H. ,
Yuan, S. P. ,
Wu, L. L. ,
Lee, F-P. ,
Lin, K. C. ,
Lai, M-T. ,
Wu, C-C. ,
Chen, T. M. ,
Chang, C. L. ,
Chow, J-M. ,
Ding, Y. F. ,
Lin, M-C. &
Wu, S-Y. ,
2016 ,
於: Medicine (United States). 95 ,
7 ,
p. e2845 研究成果: 雜誌貢獻 › 文章 › 同行評審
Induction Chemotherapy
100%
Head and Neck Neoplasms
83%
Taiwan
82%
Chemoradiotherapy
59%
Docetaxel
31%
Huang, J. S. ,
Cho, C. Y. ,
Hong, C. C. ,
Yan, M. D. ,
Hsieh, M-C. ,
Lay, J. D. ,
Lai, G. M. ,
Cheng, A. L. &
Chuang, S. E. ,
2013 ,
於: Free Radical Biology and Medicine. 65 ,
p. 1246-1256 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Oxidative Stress
100%
Reactive Oxygen Metabolite
94%
Cell Movement
82%
Reactive Oxygen Species
53%
Phosphatidylinositol 3-Kinases
33%
Zhang, J. ,
Chang, C. L. ,
Lu, C. Y. ,
Chen, H. M. &
Wu, S. Y. ,
10月 2021 ,
於: Biomedicine and Pharmacotherapy. 142 , 111991.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Conduction Anesthesia
100%
Propofol
90%
General Anesthesia
76%
Carcinoma, Ductal, Breast
56%
Breast Neoplasms
53%
pardaxin
100%
Cell Proliferation
32%
Toll-Like Receptor 2
20%
U937 Cells
20%
Leukemia
20%
Lin, L. T. ,
Uen, W. C. ,
Choong, C. Y. ,
Shi, Y. C. ,
Lee, B. H. ,
Tai, C. J. &
Tai, C. J. ,
6月 3 2019 ,
於: Molecules. 24 ,
11 , 2102.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Paris
100%
Doxorubicin
85%
drugs
83%
Autophagy
79%
Pennogenin
78%
Lawal, B. ,
Liu, Y. L. ,
Mokgautsi, N. ,
Khedkar, H. ,
Sumitra, M. R. ,
Wu, A. T. H. &
Huang, H. S. ,
2021 ,
於: Biomedicines. 9 ,
1 ,
p. 1-22 22 p. , 92.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Salicylanilide
100%
Tumor Cell Line
58%
Antitumor
53%
salicylanilide
44%
STAT3 Transcription Factor
41%
Tai, C-J. ,
Wang, W. S. ,
Chiou, T. J. ,
Liu, J. H. ,
Yen, C. C. &
Chen, P. M. ,
3月 2002 ,
於: New Taipei Journal of Medicine. 4 ,
1 ,
p. 57-62 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lin, R. K. ,
Choong, C. Y. ,
Hsu, W. H. ,
Tai, C. J. &
Tai, C. J. ,
6月 2019 ,
於: African Health Sciences. 19 ,
2 ,
p. 2156-2163 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cordyceps
100%
Mycelium
87%
Polysaccharides
60%
Doxorubicin
59%
Drug Therapy
38%
Huang, S. M. ,
Lee, C. H. ,
Chien, L. Y. ,
Liu, H. E. &
Tai, C. J. ,
9月 2004 ,
於: Journal of Advanced Nursing. 47 ,
5 ,
p. 492-499 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Thyroid Neoplasms
100%
Quality of Life
63%
Social Support
31%
Thyroidectomy
23%
Cicatrix
18%
Wang, C-W. ,
Wang, C. K. ,
Chang, Y. J. ,
Choong, C. Y. ,
Lin, C. S. ,
Tai, C. J. &
Tai, C. J. ,
2015 ,
於: Evidence-based Complementary and Alternative Medicine. 2015 , 570785.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Avemar
100%
Drug Combinations
51%
Carcinoma
32%
Docetaxel
20%
Caspase 7
17%
Tai, C. J. ,
Liao, C. F. ,
Su, T. C. ,
Shen, K. H. ,
Chang, C. C. ,
Lin, S. H. ,
Yeh, C. M. ,
Shen, S. C. ,
Lee, W. R. ,
Chiou, J. F. ,
Lin, C. H. ,
Chen, Y. C. ,
Shih, H. Y. ,
Yeh, K. T. &
Jiang, M. C. ,
7月 2012 ,
於: International Journal of Biological Markers. 27 ,
3 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cellular Apoptosis Susceptibility Protein
100%
Chromosome Segregation
62%
Urinary Bladder
40%
Urine
35%
Carcinoma
33%
Tung, J. N. ,
Tsao, T. Y. ,
Chen, S. L. ,
Tai, C. J. ,
Shen, S. C. ,
Cheng, Y. W. &
Jiang, M. C. ,
2010 ,
於: Neuroendocrinology Letters. 31 ,
3 ,
p. 390-398 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cellular Apoptosis Susceptibility Protein
100%
Matrix Metalloproteinase 2
55%
Cerebral Hemorrhage
54%
Cerebrospinal Fluid
43%
Stroke
34%
Hsieh, Y. Y. ,
Mu-Hsin Chang, P. ,
Chen, M. H. ,
Chu, P. Y. ,
Tzeng, C. H. ,
Chang, S. Y. ,
Chen, P. M. &
Yang, M. H. ,
11月 2011 ,
於: Journal of the Chinese Medical Association. 74 ,
11 ,
p. 487-492 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Squamous Cell Carcinoma of Head and Neck
100%
Medical Records
24%
Data Analysis
22%
Retrospective Studies
20%
Hsieh, C. I. ,
Lung, A. L. ,
Chang, L-I. ,
Sampselle, C. M. ,
Lin, C-C. &
Liao, Y. M. ,
6月 2013 ,
於: International Journal of Clinical Practice. 67 ,
6 ,
p. 566-575 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lower Urinary Tract Symptoms
100%
Cross-Sectional Studies
54%
Quality of Life
53%
Neoplasms
26%
Information Dissemination
6%
Hsieh, Y. Y. ,
Yang, S. T. ,
Li, W. H. ,
Hu, C. J. &
Wang, L. S. ,
4月 20 2015 ,
於: Journal of Clinical Oncology. 33 ,
12 ,
p. e57-e61 研究成果: 雜誌貢獻 › 文章 › 同行評審
Huang, K. C. ,
Li, K. J. ,
Chang, C. L. ,
Lin, C. C. &
Cho, S. ,
2020 ,
於: Value in Health Regional Issues. 22 ,
p. S107 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hsiao, P. C. ,
Chou, Y. E. ,
Tan, P. ,
Lee, W-J. ,
Yang, S. F. ,
Chow, J-M. ,
Chen, H. Y. ,
Lin, C-H. ,
Lee, L-M. &
Chien, M-H. ,
8月 21 2014 ,
於: PLoS ONE. 9 ,
8 , e105342.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Pterostilbene
100%
pterostilbene
96%
myeloid leukemia
81%
Cell Cycle Resting Phase
69%
G1 Phase
60%
Chao, T. C. ,
Chen, D. R. ,
Chao, T. Y. ,
Chen, S. C. ,
Yeh, D. C. ,
Wang, H. C. ,
Huang, W. T. ,
Rau, K. M. ,
Chang, K. J. ,
Yang, T. L. ,
Lee, K. D. ,
Tai, C. J. ,
Tseng, L. M. &
Hou, M. F. ,
12月 2013 ,
於: Anticancer Research. 33 ,
12 ,
p. 5543-5548 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Zoledronic Acid
100%
Quality of Life
49%
Breast Neoplasms
48%
Neoplasm Metastasis
47%
Bone and Bones
45%
Chang, J. L. ,
Chow, J. M. ,
Chang, J. H. ,
Wen, Y-C. ,
Lin, Y. W. ,
Yang, S. F. ,
Lee, W. J. &
Chien, M. H. ,
7月 2017 ,
於: Environmental Toxicology. 32 ,
7 ,
p. 1857-1868 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
apoptosis
100%
leukemia
97%
Cell Cycle Resting Phase
89%
HL-60 Cells
86%
Quercetin
86%
Chow, J-M. ,
Chou, K-F. ,
Chen, W-Y. ,
Lin, E-K. ,
Chang, Y. F. &
Su, Y. W. ,
2013 ,
於: Journal of Medical Cases. 4 ,
p. 466-470 研究成果: 雜誌貢獻 › 文章 › 同行評審
Thalidomide
100%
Kaposi's Sarcoma
94%
Adjuvant Chemotherapy
81%
Colonic Neoplasms
72%
Immune Reconstitution
26%
Tai, C. J. ,
Chiou, H. Y. ,
Wu, C. H. ,
Pan, S. &
Liu, J-D. ,
4月 2006 ,
於: Onkologie. 29 ,
4 ,
p. 179-180 2 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tai, C. J. ,
Lo, H. Y. ,
Hsu, C. H. ,
Tai, C. J. &
Liu, W. M. ,
4月 2006 ,
於: Gynecologic Oncology. 101 ,
1 ,
p. 184-185 2 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
GW8510
100%
ribonucleotide reductase M2
80%
Cyclin-Dependent Kinases
52%
Colorectal Neoplasms
35%
Diphosphates
19%
Ingenol Mebutate
100%
3-ingenyl angelate
83%
S100 Calcium-Binding Protein A4
77%
Colorectal Neoplasms
38%
Protein
19%
Lin, C. W. ,
Lai, G. M. ,
Chen, K. C. ,
Lin, T. H. ,
Fan, J. J. ,
Hsu, R. L. ,
Chou, C. M. ,
Lin, C. M. ,
Kandaswami, C. C. ,
Lee, M. T. &
Cheng, C. H. ,
12月 1 2015 ,
於: Journal of Functional Foods. 19 ,
p. 236-247 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
uterine cervical neoplasms
100%
Luteolin
98%
luteolin
84%
Quercetin
82%
Flavonoids
71%
貢獻的翻譯標題 : 以同步放化療治療復發左心房肉瘤:病例報告 Lu, L-S. ,
Pan, C-H. ,
Lin, Y-H. ,
Lai, H. Y. ,
Tai, C-J. ,
Hsu, CY. ,
Chiou, J-F. &
Ting, L-L. ,
2016 ,
於: Therapeutic Radiology and Oncology. p. 277-284 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tunica Intima
100%
Heart Atria
93%
Sarcoma
87%
Heart
60%
Manuscripts
53%
Sun, M. Y. ,
Chang, C. L. ,
Lu, C. Y. ,
Wu, S. Y. &
Zhang, J. Q. ,
5月 1 2022 ,
於: Nutrients. 14 ,
9 , 1910.
研究成果: 雜誌貢獻 › 文章 › 同行評審
sarcopenia
100%
cohort studies
75%
Sarcopenia
68%
Propensity Score
58%
risk factors
53%
Lin, J. ,
Hsieh, R. K. ,
Chen, J. S. ,
Lee, K. D. ,
Rau, K. M. ,
Shao, Y. Y. ,
Sung, Y. C. ,
Yeh, S. P. ,
Chang, C. S. ,
Liu, T. C. ,
Wu, M. F. ,
Lee, M. Y. ,
Yu, M. S. ,
Yen, C. J. ,
Lai, P. Y. ,
Hwang, W. L. &
Chiou, T. J. ,
4月 1 2020 ,
於: Asia-Pacific Journal of Clinical Oncology. 16 ,
2 ,
p. e91-e98 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pain Management
100%
Quality of Life
63%
Pain
57%
Neoplasms
31%
Cancer Pain
25%
Lai, I. C. ,
Liao, C. H. ,
Hu, M. H. ,
Chang, C. L. ,
Lai, G. M. ,
Chiou, T. J. ,
Hsia, S. ,
Tsai, W. L. ,
Lin, Y. Y. ,
Chuang, S. E. ,
Whang-Peng, J. ,
Chen, H. Y. &
Yao, C. J. ,
8月 2022 ,
於: Nutrients. 14 ,
15 , 3232.
研究成果: 雜誌貢獻 › 文章 › 同行評審
cisplatin
100%
Fish Oils
94%
Selenium
85%
A549 Cells
85%
fish oils
82%
Tai, C. J. ,
Chang, C. C. ,
Shen, S. C. ,
Lee, W. R. &
Jiang, M. C. ,
6月 2011 ,
於: Journal of Experimental and Clinical Medicine(Taiwan). 3 ,
3 ,
p. 104-107 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cellular Apoptosis Susceptibility Protein
100%
Blood Proteins
44%
Neoplasms
16%
Liver Neoplasms
12%
Prostatic Neoplasms
9%
Tai, C. J. ,
Choong, C. Y. ,
Shi, Y. C. ,
Lin, Y. C. ,
Wang, C-W. ,
Lee, B. H. &
Tai, C. J. ,
3月 2016 ,
於: Molecules. 21 ,
3 , 269.
研究成果: 雜誌貢獻 › 文章 › 同行評審
hyperglycemia
100%
Solanum nigrum
97%
diets
86%
fibrosis
82%
fats
65%
Chiou, J. F. ,
Tai, C. J. ,
Wang, Y. H. ,
Liu, T. Z. ,
Jen, Y. M. &
Shiau, C. Y. ,
10月 15 2009 ,
於: Cancer Biology and Therapy. 8 ,
20 ,
p. 1904-1913 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Sorafenib
100%
Hep G2 Cells
86%
Radio
83%
Mitochondria
67%
Oxidative Stress
59%
Wu, L. L. ,
Hsieh, M. C. ,
Chow, J. M. ,
Liu, S. H. ,
Chang, C. L. &
Wu, S. Y. ,
2016 ,
於: Medicine (United States). 95 ,
36 , e4639.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Hydroxymethylglutaryl-CoA Reductase Inhibitors
100%
Hepatocellular Carcinoma
82%
Radiofrequency Ablation
50%
Ethanol
38%
Injections
26%
Wang, S. W. ,
Chen, Y. R. ,
Chow, J. M. ,
Chien, M. H. ,
Yang, S. F. ,
Wen, Y. C. ,
Lee, W. J. &
Tseng, T. H. ,
7月 2018 ,
於: Molecular Carcinogenesis. 57 ,
7 ,
p. 866-877 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Luteolin
100%
Fas Ligand Protein
86%
HL-60 Cells
83%
Acetylation
75%
Histones
66%
Lay, J. D. ,
Hong, C. C. ,
Huang, J. S. ,
Yang, Y. Y. ,
Pao, C. Y. ,
Liu, C. H. ,
Lai, Y. P. ,
Lai, G. M. ,
Cheng, A. L. ,
Su, I. J. &
Chuang, S. E. ,
4月 15 2007 ,
於: Cancer Research. 67 ,
8 ,
p. 3878-3887 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Sulfasalazine
100%
Adenocarcinoma of Lung
82%
Drug Resistance
70%
Non-Small Cell Lung Carcinoma
69%
Receptor Protein-Tyrosine Kinases
49%
Kao, S. J. ,
Lee, W. J. ,
Chang, J. H. ,
Chow, J. M. ,
Chung, C. L. ,
Hung, W. Y. &
Chien, M. H. ,
4月 1 2017 ,
於: Environmental Toxicology. 32 ,
4 ,
p. 1426-1438 研究成果: 雜誌貢獻 › 文章 › 同行評審
dihydromyricetin
100%
Dihydromyricetin
98%
apoptosis
75%
reactive oxygen species
67%
JNK Mitogen-Activated Protein Kinases
63%
Sun, M. ,
Chang, C. L. ,
Lu, C. Y. ,
Wu, S. Y. &
Zhang, J. ,
3月 2022 ,
於: Journal of Personalized Medicine. 12 ,
3 , 384.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Tramadol
100%
Propensity Score
84%
Chronic Pain
71%
Cohort Studies
53%
Analgesics
52%
Tai, C. J. ,
Chin-Sheng, H. ,
Kuo, L. J. ,
Wei, P. L. ,
Lu, H. H. ,
Chen, H. A. ,
Liu, T. Z. ,
Liu, J. J. ,
Liu, D. Z. ,
Ho, Y. S. ,
Wu, C. H. &
Chang, Y. J. ,
1月 2012 ,
於: Annals of Surgical Oncology. 19 ,
1 ,
p. 336-343 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
glucose-regulated proteins
100%
Survivin
86%
Epithelial-Mesenchymal Transition
74%
Cell Movement
59%
Hepatocellular Carcinoma
26%
Wu, H. J. ,
Tai, C. J. ,
Tai, C. J. &
Chien, L. Y. ,
1月 2019 ,
於: European Journal of Cancer Care. 28 ,
1 , e12925.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Complementary Therapies
100%
Taiwan
97%
Colorectal Neoplasms
78%
Breast Neoplasms
62%
Cancer Survivors
33%
Hsieh, Y. Y. ,
Huang, T. C. ,
Lo, H. L. ,
Jhan, J. Y. ,
Chen, S. T. &
Yang, P. M. ,
5月 10 2016 ,
於: Oncotarget. 7 ,
19 ,
p. 27363-27378 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Azacitidine
100%
Decitabine
97%
Drug Discovery
77%
Genomics
75%
Polypharmacology
35%
Liu, T. P. ,
Hsieh, Y. Y. ,
Chou, C. J. &
Yang, P. M. ,
11月 1 2018 ,
於: Royal Society Open Science. 5 ,
11 ,
p. 181321 181321.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Polypharmacology
100%
Drug Repositioning
82%
Databases
36%
Pharmaceutical Preparations
20%
Topoisomerase Inhibitors
15%
Tai, C. J. ,
Shi, Y. C. ,
Tai, C. J. ,
Kuo, L. J. ,
Chen, R. J. ,
Chang, Y. J. ,
Tzao, C. ,
Wu, C. H. ,
Chang, C. C. ,
Chiou, H. Y. &
Su, C. H. ,
3月 1 2020 ,
於: Alternative Therapies in Health and Medicine. 24 ,
12 ,
p. 18-22 研究成果: 雜誌貢獻 › 文章 › 同行評審
Amphotericin B
100%
Drug Therapy
53%
Response Evaluation Criteria in Solid Tumors
32%
Ethanol
32%
Neoplasms
29%
Tai, C. J. ,
Jassey, A. ,
Liu, C. H. ,
Tai, C. J. ,
Richardson, C. D. ,
Wong, S. H. &
Lin, L. T. ,
4月 8 2020 ,
於: Cells. 9 ,
4 研究成果: 雜誌貢獻 › 文章 › 同行評審
Berberine
100%
Autophagy
71%
Hepacivirus
68%
Hepatocellular Carcinoma
59%
Cell Death
56%
Lai, T-I. ,
Yao, C. J. ,
Yang, C. M. ,
Chuang, S. E. ,
Yan, J. L. ,
Liu, C. Y. ,
Chen, S. W. ,
Yan, K. H. &
Lai, G. M. ,
2011 ,
於: Evidence-based Complementary and Alternative Medicine. 2011 , 984154.
研究成果: 雜誌貢獻 › 文章 › 同行評審
tien-hsien liquid
100%
Acute Promyelocytic Leukemia
54%
Apoptosis
7%
Arsenic Trioxide
5%
Cyclin B1
5%